SYNTHON HISPANIA SL
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about SYNTHON HISPANIA SL
Live alerts from global media, monitored by Business Radar
2020-04-16 (businesswire.com)
Synthon Biopharmaceuticals Relaunches as Byondis
Synthon Biopharmaceuticals B.V., a biopharmaceutical research and development company creating innovative precision medicines for patients with relent
Read more
2014-02-04 (vaktechnisch.nl)
Start new construction mAb Plant Synthon
Last week, pharmaceutical company Synthon gave the official go-ahead for the realization of a new factory on the Microweg in Nijmegen. In this so-called mAb plant, the company will produce therapeutic monoclonal antibodies.
Read more